hoe 33342 and Triple Negative Breast Neoplasms

hoe 33342 has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berindan-Neagoe, I; Braicu, C; Irimie, A; Pileczki, V	1

Other Studies

1 other study(ies) available for hoe 33342 and Triple Negative Breast Neoplasms

Article	Year
p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells. Molecular and cellular biochemistry, 2013, Volume: 381, Issue:1-2 Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Flow Cytometry; Gene Regulatory Networks; Genetic Association Studies; Humans; Immunoblotting; Microscopy, Fluorescence; RNA, Small Interfering; Staining and Labeling; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53	2013

Article

Year

p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells.

Molecular and cellular biochemistry, 2013, Volume: 381, Issue:1-2

Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Flow Cytometry; Gene Regulatory Networks; Genetic Association Studies; Humans; Immunoblotting; Microscopy, Fluorescence; RNA, Small Interfering; Staining and Labeling; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53

2013